Literature DB >> 23126347

Cost-effectiveness evaluation of a collaborative patient education hypertension intervention in Utah.

Justin G Trogdon1, Barbara Larsen, David Larsen, Wendy Salas, Matt Snell.   

Abstract

This study analyzed the cost-effectiveness of a patient hypertension education intervention that provided patient education through interactive voice response technology and distribution of automated blood pressure monitors to high-risk plan members with uncontrolled hypertension. A total of 17,318 members were identified with hypertension in an administrative database. The study sample consisted of all 534 high-risk hypertensive plan members who received blood pressure monitors. Using data on activity-based program costs and changes in hypertension control, this study modeled the intervention's cost-effectiveness relative to no intervention. The intervention was estimated to have brought hypertension under control in 151 patients during the study year. Across all 534 participants in 1 year, 0.3 events (acute myocardial infarction, stroke, congestive heart failure, and renal failure) were avoided and 2.77 life-years were gained (LYG). The incremental cost-effectiveness ratio (ICER) for the intervention compared with no intervention was $767 per person brought under control or $41,927 per LYG. If the gains in hypertension control from 1 year's investment were assumed to last 10 years, the 10-year ICER relative to no intervention was $1857 per LYG. The intervention is a cost-effective strategy to address hypertension and can serve as a model for future innovations.
© 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 23126347      PMCID: PMC8108965          DOI: 10.1111/jch.12013

Source DB:  PubMed          Journal:  J Clin Hypertens (Greenwich)        ISSN: 1524-6175            Impact factor:   3.738


  11 in total

1.  US trends in prevalence, awareness, treatment, and control of hypertension, 1988-2008.

Authors:  Brent M Egan; Yumin Zhao; R Neal Axon
Journal:  JAMA       Date:  2010-05-26       Impact factor: 56.272

2.  Targets and self monitoring in hypertension: randomised controlled trial and cost effectiveness analysis.

Authors:  R J McManus; J Mant; A Roalfe; R A Oakes; S Bryan; H M Pattison; F D R Hobbs
Journal:  BMJ       Date:  2005-08-22

Review 3.  Cost effectiveness of coronary heart disease prevention strategies in adults.

Authors:  A D Brown; A M Garber
Journal:  Pharmacoeconomics       Date:  1998-07       Impact factor: 4.981

4.  Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.

Authors:  Aram V Chobanian; George L Bakris; Henry R Black; William C Cushman; Lee A Green; Joseph L Izzo; Daniel W Jones; Barry J Materson; Suzanne Oparil; Jackson T Wright; Edward J Roccella
Journal:  Hypertension       Date:  2003-12-01       Impact factor: 10.190

Review 5.  Hypertension: trends in prevalence, incidence, and control.

Authors:  Ihab Hajjar; Jane Morley Kotchen; Theodore A Kotchen
Journal:  Annu Rev Public Health       Date:  2006       Impact factor: 21.981

6.  Blood pressure control by home monitoring: meta-analysis of randomised trials.

Authors:  Francesco P Cappuccio; Sally M Kerry; Lindsay Forbes; Anna Donald
Journal:  BMJ       Date:  2004-06-11

7.  The cost-effectiveness of counseling smokers to quit.

Authors:  S R Cummings; S M Rubin; G Oster
Journal:  JAMA       Date:  1989-01-06       Impact factor: 56.272

Review 8.  Cost-effectiveness analysis in heart disease, Part II: Preventive therapies.

Authors:  J Kupersmith; M Holmes-Rovner; A Hogan; D Rovner; J Gardiner
Journal:  Prog Cardiovasc Dis       Date:  1995 Jan-Feb       Impact factor: 8.194

9.  Home blood pressure monitoring. Effect on use of medical services and medical care costs.

Authors:  K Soghikian; S M Casper; B H Fireman; E M Hunkeler; L B Hurley; I S Tekawa; T M Vogt
Journal:  Med Care       Date:  1992-09       Impact factor: 2.983

10.  Blood pressure and end-stage renal disease in men.

Authors:  M J Klag; P K Whelton; B L Randall; J D Neaton; F L Brancati; C E Ford; N B Shulman; J Stamler
Journal:  N Engl J Med       Date:  1996-01-04       Impact factor: 91.245

View more
  7 in total

1.  A hypertension emergency department intervention aimed at decreasing disparities: Design of a randomized clinical trial.

Authors:  Heather M Prendergast; Marina Del Rios; Renee Petzel-Gimbar; Daniel Garside; Sara Heinert; Sandra Escobar-Schulz; Pavitra Kotini-Shah; Michael Brown; Jinsong Chen; Joseph Colla; Marian Fitzgibbon; Ramon A Durazo-Arvizu; Martha Daviglus
Journal:  Contemp Clin Trials       Date:  2017-11-08       Impact factor: 2.226

Review 2.  Economics of Self-Measured Blood Pressure Monitoring: A Community Guide Systematic Review.

Authors:  Verughese Jacob; Sajal K Chattopadhyay; Krista K Proia; David P Hopkins; Jeffrey Reynolds; Anilkrishna B Thota; Christopher D Jones; Daniel T Lackland; Kimberly J Rask; Nicolaas P Pronk; John M Clymer; Ron Z Goetzel
Journal:  Am J Prev Med       Date:  2017-08-14       Impact factor: 5.043

Review 3.  Systematic Review of Self-Measured Blood Pressure Monitoring With Support: Intervention Effectiveness and Cost.

Authors:  Sharada S Shantharam; Mallika Mahalingam; Aysha Rasool; Jeffrey A Reynolds; Aunima R Bhuiya; Tyra D Satchell; John M Chapel; Nikki A Hawkins; Christopher D Jones; Verughese Jacob; David P Hopkins
Journal:  Am J Prev Med       Date:  2021-10-20       Impact factor: 5.043

4.  Cardiovascular Events and Costs With Home Blood Pressure Telemonitoring and Pharmacist Management for Uncontrolled Hypertension.

Authors:  Karen L Margolis; Steven P Dehmer; JoAnn Sperl-Hillen; Patrick J O'Connor; Stephen E Asche; Anna R Bergdall; Beverly B Green; Rachel A Nyboer; Pamala A Pawloski; Nicole K Trower; Michael V Maciosek
Journal:  Hypertension       Date:  2020-08-31       Impact factor: 10.190

Review 5.  Exploring issues in difficult-to-treat hypertension.

Authors:  Michael A Weber
Journal:  J Clin Hypertens (Greenwich)       Date:  2013-10-30       Impact factor: 3.738

6.  Effectiveness and Efficiency of Non-drug Therapy Among Community-Dwelling Adults With Hypertension in China: A Protocol for Network Meta-Analysis and Cost-Effectiveness Analysis.

Authors:  Taihang Shao; Xia Li; Chengchao Zhou; Xiao Zang; Daniel C Malone; Liang Zhang; Jifang Zhou; Wenxi Tang
Journal:  Front Med (Lausanne)       Date:  2021-02-25

Review 7.  A Systematic Review of Economic Evidence on Community Hypertension Interventions.

Authors:  Donglan Zhang; Guijing Wang; Heesoo Joo
Journal:  Am J Prev Med       Date:  2017-12       Impact factor: 5.043

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.